alopecia areata

What Dermatologists Should Know About Approaching Alopecia Patients
alopeciaNext Steps in Derm, in partnership with Skin of Color Update, interviewed dermatologist Dr. Victoria Barbosa, associate professor at University of Chicago Medicine. Watch as Dr. Barbosa shares why it may be challenging for an alopecia patient to visit a dermatologist and why it’s important to address the psychological burden of hair loss. Hear how considering a broad differential is essential t …
alopecia
Alopecia Areata – Friday Pop Quiz – 01/12/2024
A 39-year-old woman with a history of alopecia areata presents for evaluation of multiple macules and patches on her left mandibular face. She developed these lesions slowly over several years, where they have remained stable for many years. The patient’s goal now is to achieve repigmentation of the lesions. The patient has previously used topical hydrocortisone 1% cream on the lesions …
Topical Ruxolitinib Therapeutic Cheat Sheet
RuxolitinibRuxolitinib (OPZELURA) is a twice daily topical cream that is FDA approved for non-segmental vitiligo and mild to moderate atopic dermatitis1. JAK inhibitors are a class of drugs effective in treating a wide variety of inflammatory conditions. Initially only FDA approved for non-dermatologic conditions such as rheumatoid arthritis and ulcerative colitis, there is now strong evidence that JAK/STAT …
Ruxolitinib
Medicolegal Implications of Regenerative Medicine and PRP
PRPNext Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed Dr. Terrance Keaney, assistant clinical faculty of dermatology at GW School of Medicine and Health Sciences, and Howard University. Watch and find out why the FDA and Department of Justice are giving more attention to regenerative medicine in recent years. Learn how the FDA views platelet-ri …
PRP